TouchMDT: Precision Targeting Of MET In NSCLC: A Multidisciplinary Approach

Player FM - Internet Radio Done Right

הוסף לפני three שנים

תוכן מסופק על ידי touchpodcast. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי touchpodcast או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.

Profits Through Podcasting

1
100 Episodes WASTED! Fix These 4 Simple Podcast Blunders in Minutes 14:42

לפני 8 weeks14:42

הפעל מאוחר יותר

רשימות

לייק

אהבתי

14:42

Is your health and wellness podcast optimized for success, or are crucial oversights holding back your potential? I audited a doctor’s podcast recently and was shocked at what I found. This podcast had over 100 episodes—pretty impressive. However, the whole setup of the podcast had some brutal mistakes that I’m sure were holding this doctor back from seeing bigger results. How can optimizing your podcast's website links transform your show's reach? Are you missing out on SEO benefits that could elevate your visibility? Curious about the impact of professional collaboration on your podcast? Don't let simple mistakes hold you back. Tune in to find out how to turn your podcast into a lead-generating powerhouse! Today’s episode includes: How minor mistakes hinder podcast growth and engagement. Why directing podcast episode links on Apple, Spotify, etc to your own website is ideal. Why collaborating with professional teams can elevate your podcast impact and revenue. How maintaining high production standards enhances credibility, especially in the health and wellness space. How omitting crucial subscription links will limit your audience growth. Why owning a proper domain ensures long-term SEO benefits and authority with search engines. How missing social media links in your show notes makes it difficult for listeners to connect with you. Why understanding and avoiding common mistakes ensures maximum ROI from podcasting efforts. Are you pouring your heart into your podcast but still not seeing the growth you deserve? Download our free guide to unlock your podcast’s full potential and expand your impact: https://eastcoaststudio.com/5mistakes Our LinkedIn: https://www.linkedin.com/company/eastcoaststudio/ Our Instagram: https://www.instagram.com/ecpodcaststudio/…

touchPODCAST « »
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

לפני שנה 13:46

שתפו

MP3•בית הפרקים

touchMDT for touchONCOLOGY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.

The multidisciplinary team

Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany

This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:

www.touchONCOLOGY.com

102 פרקים

#Science #TouchPODCAST

touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

touchPODCAST

published לפני שנה

שתפו

MP3•בית הפרקים

touchMDT for touchONCOLOGY
Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.

The multidisciplinary team

Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany

www.touchONCOLOGY.com

102 פרקים

#Science #TouchPODCAST

כל הפרקים

touchPODCAST

1
RET-positive NSCLC: Translating insights into targeted approaches 14:36

לפני 8 ימים14:36

14:36

touchFOCUS for touchONCOLOGY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc . This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchoncology.com…

touchPODCAST

1
RET-positive NSCLC: Translating insights into targeted approaches 14:36

לפני 8 ימים14:36

14:36

touchFOCUS for touchRESPIRATORY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc . This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchrespiratory.com…

touchPODCAST

1
Advances in dry eye disease: From diagnosis to new treatment targets 37:43

לפני 14 ימים37:43

37:43

touchEXPERT FOCUS touchOPHTHALMOLOGY Listen to Dr Laura Periman share expert insights on dry eye disease. In this episode, she explores the pathophysiological mechanisms behind the condition, highlights key diagnostic tools, reviews current treatment options—including exciting advances in neuromodulation therapies—and discusses emerging targeted approaches shaping clinical management today. The expert Dr Laura Periman, Periman Eye Institute, Seattle, WA, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from A lcon Vision, LLC. The activity is jointly provided by USF Health and touchIME. For further information, visit our website: https://touchophthalmologyime.org/advances-in-dry-eye-disease/…

touchPODCAST

1
Recent advances in the care of patients with geographic atrophy: Bringing new and emerging therapies into focus 35:33

לפני 16 ימים35:33

35:33

touchIN CONVERSATION for touchOPHTHALMOLOGY Listen to two experts in geographic atrophy (GA) discuss recent advances in the care of patients. They explore the importance of early identification of GA and how this can be achieved, examine the potential impact of new and emerging therapies for GA, and highlight key practical considerations for monitoring treatment outcomes and evaluating effectiveness of therapy in clinical practice. The experts Prof. Giuseppe Querques, IRCCS Hospital San Raffaele, Milan, Italy Dr Arshad M. Khanani, Sierra Eye Associates, Reno, NV, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Astellas Pharma Inc. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchophthalmologyime.org/…

touchPODCAST

1
The potential of BTKi therapies in delaying MS progression 13:32

לפני 22 ימים13:32

13:32

touchEXPERT FOCUS for touchNEUROLOGY Join Prof. Montalban as he shares expert insights into the pathophysiology of progressive MS and the rationale for targeting BTK inhibitors. He reviews emerging clinical data supporting the use of BTK inhibitors and discusses how they may fit into the evolving treatment landscape. In this context, Prof. Montalban also considers current guideline-recommended therapies for progressive MS and highlights key areas of remaining unmet treatment need. The expert Prof. Xavier Montalban, Centre d'Esclerosi Múltiple de Catalunya (Cemcat) and Vall d'Hebron University Hospital, Barcelona, Spain This touchPODCAST is for HCPs outside of the UK only. This activity is provided by an independent medical education grant from Sanofi. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchneurology.com/…

touchPODCAST

1
Reducing burden of disease in gMG: Exploring the role of FcRn inhibitors 30:27

לפני 22 ימים30:27

30:27

touchPANEL DISCUSSION for touchNEUROLOGY Listen to two expert neurologists and a neurology nurse as they explore the role of neonatal Fc receptor (FcRn) inhibitors in improving the burden of disease in patients with generalized myasthenia gravis. The faculty will consider how the burden of disease and treatment in patients with generalized myasthenia gravis can be used to inform treatment decisions, the latest clinical data for FcRn inhibitors and the best practice strategies for using FcRn inhibitors in clinical practice. The experts Prof. Michael Nicolle – Western University and London Health Sciences Centre, London, ON, Canada Dr Karissa Gable – Duke University, Durham, NC, USA Ms Missy Pittman – Duke University, Durham, NC, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Argenx and UCB, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchneurologyime.org/reducing-burden-of-disease-in-gmg-exploring-the-role-of-fcrn-inhibitors/…

touchPODCAST

1
MDT perspectives on why and how to implement continuous glucose monitoring in T2D 13:26

לפני 22 ימים13:26

13:26

Listen to key experts from a multidisciplinary team review and discuss why and how to implement continuous glucose monitoring in T2D. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa Nurse specialist: Ms. Lori Berard Patient advocate: Mr. Ostap Soroka This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/…

touchPODCAST

1
MDT perspectives on evolving options for insulin therapy 10:05

לפני 22 ימים10:05

10:05

Listen to key experts from a multidisciplinary team review and discuss evolving options for insulin therapy. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/…

touchPODCAST

1
MDT perspectives on understanding clinical inertia in T2D 12:14

לפני 22 ימים12:14

12:14

Listen to key experts from a multidisciplinary team review and discuss clinical inertia in T2D. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa Patient advocate: Mr. Ostap Soroka This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchendocrinologyime.org/mdt-empowering-t2d-management-the-evolution-of-basal-insulin-therapy/…

touchPODCAST

1
Navigating the clinical impact of TROP2-targeting in NSCLC 55:41

לפני 29 ימים55:41

55:41

touchSYMPOSIUM for touchONCOLOGY Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France. Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC. Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/…

touchPODCAST

1
Navigating the clinical impact of TROP2-targeting in NSCLC 55:41

לפני 29 ימים55:41

55:41

touchSYMPOSIUM for touchRESPIRATORY Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France. Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC. Session 1: Prof. Marina Garassino highlights the emergence of TROP2 in NSCLC as a promising area of therapeutic innovation Session 2: Prof. Jaruska Naidoo discusses the latest clinical trial findings for TROP2-targeting ADCs in NSCLC Session 3: Prof. David Planchard discusses the complexities of using TROP2 as a biomarker for patient selection Session 4: A panel discussion offering practical approaches for managing adverse effects associated with TROP2-targeted ADCs in clinical practice, with Q&A. This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Daiichi Sankyo and AstraZeneca and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/…

touchPODCAST

1
Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchNEUROLOGY 33:43

לפני 6 weeks33:43

33:43

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes. The experts Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA Dr Christina Lampe, University of Giessen, Giessen, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Chiesi USA, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit: touchneurologyime.org/…

touchPODCAST

1
Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchENDOCRINOLOGY 33:45

לפני 6 weeks33:45

33:45

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of alpha-mannosidosis, with the aim of optimizing patient outcomes. The experts Dr Barbara K. Burton, Northwestern University Feinberg School of Medicine, Chicago, IL, USA Dr Can Ficicioglu, Children's Hospital of Philadelphia, PA, USA Dr Christina Lampe, University of Giessen, Giessen, Germany This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Chiesi USA, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit: touchendocrinologyime.org/…

touchPODCAST

1
The evolving standard of care for advanced/recurrent endometrial cancer: A practice-focused discussion of immunotherapy 38:58

לפני 6 weeks38:58

38:58

touchIN CONVERSATION for touchONCOLOGY Listen to two expert gynaecologic oncology specialists discuss the evolving role of immunotherapy in the treatment of advanced/recurrent endometrial cancer. They explore how immune checkpoint inhibitors are reshaping standards of care across lines of therapy, highlight key practical considerations for optimizing patient selection and management, and examine emerging data that may influence future treatment paradigms. The experts Dr Alexandra Leary, Gustave Roussy Cancer Center, Villejuif, France Dr Juan Francisco Grau, Gustave Roussy Cancer Center, Villejuif, France This touchPODCAST is for HCPs outside of the USA and UK only. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/…

touchPODCAST

1
Tailoring treatment in myelofibrosis: Addressing anaemia and thrombocytopenia 35:35

לפני 7 weeks35:35

35:35

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three experts as they explore the burden of myelofibrosis and anaemia and/or thrombocytopenia, discuss targeted treatment strategies and how to maximize benefits for patients. The experts Prof. Haifa Kathrin Al-Ali – University Hospital of Halle, Halle (Saale), Germany Prof. Jean-Jacques Kiladjian – Université Paris Cité and Saint-Louis Hospital, Paris, France Prof. Alessandro Vannucchi – University of Florence, Florence, Italy This touchPODCAST is for HCPs outside of the UK and USA only. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchhaematologyime.org/…

ברוכים הבאים אל Player FM!

Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.

תקשיבו ל-500+ נושאים

דומה לtouchPODCAST

USANOOKS Microfiber Cleaning Cloth Grey - 12 Pcs (12.5"x12.5") - High Performance - 1200 Washes, Ultra Absorbent Microfiber Towel Weave Grime & Liquid for Streak-Free Mirror Shine - Car Washing Cloth

Betem 24 Colors Dual Tip Acrylic Paint Pens Markers, Premium Acrylic Paint Pens for Wood, Canvas, Stone, Rock Painting, Glass, Ceramic Surfaces, DIY Crafts Making Art Supplies

Neenah Index Cardstock, 8.5" x 11", 90 lb/163 gsm, White, Lightweight, 94 Brightness, 300 Sheets (91437)

פודקאסטים ששווה להאזין

touchPODCAST « » touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

פודקאסטים ששווה להאזין

ברוכים הבאים אל Player FM!

CERAKOTE® Ceramic Headlight Restoration Kit – Guaranteed To Last As Long As You Own Your Vehicle – Brings Headlights Back to Like New Condition - No Power Tools Required - 10 Wipe Kit

Astrobrights/Neenah Bright White Cardstock, 8.5" x 11", 65 lb/176 gsm, White, 75 Sheets (90905-02) - Packaging May Vary

FITTDYHE Fabric Glue Permanent, 60 ML Washable Clear Clothing Glue, Super Fabric Adhesive for Rhinestones, Patches, Clothes, Denim, Leather, Polyester, Fabrics, Doll Repair, Flannel, Cotton

Car Phone Holder for Magsafe [78+LBS Strongest Suction & 2400gf Strongest Magnetic] 360° Adjustable Car Phone Mount, Phone Holders for Your Car for iPhone 16 Pro Max 15 14 13 12 Plus (Carbon Fiber)

דומה לtouchPODCAST

מדריך עזר מהיר

touchPODCAST « »
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4